BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38554330)

  • 1. A comparative study of whole brain radiotherapy with concomitant thalidomide versus whole brain radiotherapy alone in brain metastases.
    Chyrmang D; Devi YS; Baidya K; Singh LJ; Nongrum DL; Devi ND
    J Cancer Res Ther; 2024 Jan; 20(1):255-260. PubMed ID: 38554330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
    Tsao MN; Lloyd N; Wong RK; Chow E; Rakovitch E; Laperriere N; Xu W; Sahgal A
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003869. PubMed ID: 22513917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
    Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.
    Mandell LR; Kadota R; Freeman C; Douglass EC; Fontanesi J; Cohen ME; Kovnar E; Burger P; Sanford RA; Kepner J; Friedman H; Kun LE
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):959-64. PubMed ID: 10192340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1.
    Robinet G; Thomas P; Breton JL; Léna H; Gouva S; Dabouis G; Bennouna J; Souquet PJ; Balmes P; Thiberville L; Fournel P; Quoix E; Riou R; Rebattu P; Pérol M; Paillotin D; Mornex F
    Ann Oncol; 2001 Jan; 12(1):59-67. PubMed ID: 11249050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole brain radiotherapy for the treatment of multiple brain metastases.
    Tsao MN; Lloyd N; Wong R; Chow E; Rakovitch E; Laperriere N
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003869. PubMed ID: 16856022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx.
    Fallai C; Bolner A; Signor M; Gava A; Franchin G; Ponticelli P; Taino R; Rossi F; Ardizzoia A; Oggionni M; Crispino S; Olmi P
    Tumori; 2006; 92(1):41-54. PubMed ID: 16683383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External beam radiation dose escalation for high grade glioma.
    Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
    Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis.
    Fuentes R; Osorio D; Expósito Hernandez J; Simancas-Racines D; Martinez-Zapata MJ; Bonfill Cosp X
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012086. PubMed ID: 30125049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.
    Tsao MN; Lloyd NS; Wong RK; Rakovitch E; Chow E; Laperriere N;
    Cancer Treat Rev; 2005 Jun; 31(4):256-73. PubMed ID: 15951117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole Brain Radiotherapy Versus Stereotactic Radiosurgery in Poor-Prognosis Patients with One to 10 Brain Metastases: A Randomised Feasibility Study.
    Raman S; Mou B; Hsu F; Valev B; Cheung A; Vallières I; Ma R; McKenzie M; Beaton L; Rackley T; Gondara L; Nichol A
    Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):442-451. PubMed ID: 32085923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.
    Hwu WJ; Lis E; Menell JH; Panageas KS; Lamb LA; Merrell J; Williams LJ; Krown SE; Chapman PB; Livingston PO; Wolchok JD; Houghton AN
    Cancer; 2005 Jun; 103(12):2590-7. PubMed ID: 15861414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
    Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05.
    Phillips TL; Scott CB; Leibel SA; Rotman M; Weigensberg IJ
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):339-48. PubMed ID: 7673021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme.
    Turner CD; Chi S; Marcus KJ; MacDonald T; Packer RJ; Poussaint TY; Vajapeyam S; Ullrich N; Goumnerova LC; Scott RM; Briody C; Chordas C; Zimmerman MA; Kieran MW
    J Neurooncol; 2007 Mar; 82(1):95-101. PubMed ID: 17031553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.
    Murray KJ; Scott C; Greenberg HM; Emami B; Seider M; Vora NL; Olson C; Whitton A; Movsas B; Curran W
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):571-4. PubMed ID: 9336134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for brain metastases from small cell lung cancer.
    Reveiz L; Rueda JR; Cardona AF
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007464. PubMed ID: 22696370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study on different doses and fractionated radiotherapies for multiple brain metastases of non-EGFR mutant lung adenocarcinoma.
    Liu H; Xu X; Wang J; Wang W; Ma C; Sun T; Shao Q
    Ann Palliat Med; 2020 Jul; 9(4):2003-2012. PubMed ID: 32692247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trial.
    Gamboa-Vignolle C; Ferrari-Carballo T; Arrieta Ó; Mohar A
    Radiother Oncol; 2012 Feb; 102(2):187-91. PubMed ID: 22257825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.